Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis

[1]  H. Koga,et al.  CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis , 2014, Journal of gastroenterology and hepatology.

[2]  W. Parks,et al.  Diverse functions of matrix metalloproteinases during fibrosis , 2014, Disease Models & Mechanisms.

[3]  S. Warren,et al.  Quality-Control Culture System Restores Diabetic Endothelial Progenitor Cell Vasculogenesis and Accelerates Wound Closure , 2013, Diabetes.

[4]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[5]  H. Masuda,et al.  Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord , 2013, Journal of the Neurological Sciences.

[6]  N. Lanthier,et al.  Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial , 2013, PloS one.

[7]  H. Koga,et al.  Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride‐induced rat liver cirrhotic model , 2013, Journal of gastroenterology and hepatology.

[8]  M. Kurosaka,et al.  Local Transplantation of Ex Vivo Expanded Bone Marrow-Derived CD34-Positive Cells Accelerates Fracture Healing , 2012, Cell transplantation.

[9]  H. Koga,et al.  Prevention of liver fibrosis and liver reconstitution of DMN‐treated rat liver by transplanted EPCs , 2012, European journal of clinical investigation.

[10]  H. Koga,et al.  Human peripheral blood CD34‐positive cells enhance therapeutic regeneration of chronically injured liver in nude rats , 2012, Journal of cellular physiology.

[11]  H. Masuda,et al.  Development of Serum‐Free Quality and Quantity Control Culture of Colony‐Forming Endothelial Progenitor Cell for Vasculogenesis , 2012, Stem cells translational medicine.

[12]  W. Semmler,et al.  Cilengitide inhibits metastatic bone colonization in a nude rat model. , 2011, Oncology reports.

[13]  Y. M. Lee,et al.  Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. , 2011, Journal of molecular and cellular cardiology.

[14]  H. Masuda,et al.  Methodological Development of a Clonogenic Assay to Determine Endothelial Progenitor Cell Potential , 2011, Circulation research.

[15]  J. Y. Kim,et al.  Human Cord Blood-Derived Endothelial Progenitor Cells and Their Conditioned Media Exhibit Therapeutic Equivalence for Diabetic Wound Healing , 2010, Cell transplantation.

[16]  M. Zern,et al.  Autologous Hematopoietic Stem Cell Transplantation in 48 Patients with End-Stage Chronic Liver Diseases , 2010, Cell transplantation.

[17]  D. Schuppan,et al.  Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis , 2009, Hepatology.

[18]  Shahid A. Khan,et al.  Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis , 2008, The American Journal of Gastroenterology.

[19]  S. Warren,et al.  The Effects of Flap Ischemia on Normal and Diabetic Progenitor Cell Function , 2008, Plastic and reconstructive surgery.

[20]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[21]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[22]  E. Taniguchi,et al.  Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. , 2007, Gastroenterology.

[23]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[24]  S. Forbes,et al.  Bone marrow stem cells and liver disease , 2006, Gut.

[25]  S. Terai,et al.  Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy , 2006, Stem cells.

[26]  M. Kurosaka,et al.  Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. , 2006, The American journal of pathology.

[27]  A. Avogaro,et al.  Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[28]  R. Lechler,et al.  Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor , 2006, Stem cells.

[29]  K. Asahina,et al.  Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease. , 2006, Current stem cell research & therapy.

[30]  D. Ribatti,et al.  Biological and molecular properties of a new αvβ3/αvβ5 integrin antagonist , 2005, Molecular Cancer Therapeutics.

[31]  D. Häussinger,et al.  Portal Application of Autologous CD133+ Bone Marrow Cells to the Liver: A Novel Concept to Support Hepatic Regeneration , 2005, Stem cells.

[32]  Michael S. Pepper,et al.  αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro , 2004, Angiogenesis.

[33]  O. Kuss,et al.  Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting , 2003 .

[34]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[35]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[36]  S. Goodman,et al.  alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. , 2003, Angiogenesis.

[37]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[38]  Horst Kessler,et al.  Nanomolar Small Molecule Inhibitors for αvβ6, αvβ5, and αvβ3 Integrins , 2002 .

[39]  S. Goodman,et al.  Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins. , 2002, Journal of medicinal chemistry.

[40]  Naohiro Terada,et al.  Hepatic maturation in differentiating embryonic stem cells in vitro , 2001, FEBS letters.

[41]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[42]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[44]  D. Cheresh,et al.  Review: The Integrin αvβ3: Angiogenesis and Apoptosis , 1995 .

[45]  D. Cheresh,et al.  REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis. , 1995, Cell adhesion and communication.